Stock info Dechra Pharmaceuticals | Filter  Basic-Info

Dechra Pharmaceuticals

The period from 2006 till the end of 2016 the international sector gained around 75 percent. Over the past 5 years the sector is 147 percent higher.

The past year gave good returns for Dechra Pharmaceuticals investors

Over the last 12 months (from December 2015 till December 2016), that were profitable period for the investors in Dechra Pharmaceuticals, the stock gained around 29 percent. Over the past 5 years Dechra Pharmaceuticals' stock rose at around 202 percent in value. Dechra Pharmaceuticals's revenues between 2011 and 2015 were quite unstable and moved between 42,6 billion GBp and 20,35 billion GBp. Dechra Pharmaceuticals's net incomes between 2011 and 2015 were quiet similar and moved between 1,6 billion GBp and 1,74 billion GBp.

The English company paid out dividends in the past 5 years. On average Dechra Pharmaceuticals's dividend yield over the past 5 years was around 69,73 percent annually. Over the past 5 years Dechra Pharmaceuticals raised her dividends share each year. Based on the raising dividend payments Dechra Pharmaceuticals can be seen as a kind of dividend aristocrat.

Dechra Pharmaceuticals financed with relatively low debt

Last year the balance sheet of the English company was worth 29,21 billion GBp. 9,76 billion GBp (33,42 percent of the total balance sheet) was financed by debt.

At the end of 2015 around 87,89 million stocks were listed.

All of Dechra Pharmaceuticals's annual reports are stored here. More information about Dechra Pharmaceuticals can be found it's website. .